Amu Wang

Personalising screening of sight-threatening diabetic retinopathy - qualitative evidence to inform effective implementation

James G. Lathe, M. García-Fiñana, I. Stratton, 2020, BMC Public Health.

Incidence of sight‐threatening diabetic retinopathy in an established urban screening programme: An 11‐year cohort study

James G. Lathe, M. García-Fiñana, S. Harding, 2021, Diabetic medicine : a journal of the British Diabetic Association.

Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules

M. García-Fiñana, S. Harding, I. Stratton, 2018, Diabetes, obesity & metabolism.

Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT

James G. Lathe, M. García-Fiñana, S. Harding, 2020, Diabetologia.

Individualised screening for diabetic retinopathy: the ISDR study—rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening

M. García-Fiñana, S. Harding, I. Stratton, 2019, BMJ Open.

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

Simon P. Harding, Antonio Eleuteri, Anthony C. Fisher, 2017, Diabetologia.

Patient recruitment to a diabetic retinopathy screening trial through optimised patient information materials: an embedded study within a trial (SWAT)

P. Bower, P. Knapp, Tracy Moitt, 2020, F1000Research.

Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials

M. García-Fiñana, S. Harding, A. Eleuteri, 2015, Trials.